Adenosine A2A receptor antagonist
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Adenosine A2A receptor antagonist, covering 2026-03-20 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Adenosine 2A Receptor Antagonism and AIH in ALS [Phase 1, Phase 2]